IP Library Granted Patent US 9,173,973
Granted Patent B2
US 9,173,973 · App. 13/370,394 · Granted Nov 3, 2015

Bioabsorbable polymeric composition for a medical device

Inventors: G. Lawrence Thatcher (Chelmsford, MA); Robert J. Cottone (Davie, FL)
A61L27/26A61L27/18A61L27/58A61L31/06B29C47/0066B29C2793/009B29C2793/0018B29K2067/046B29K2105/0085B29K2995/006B29L2031/7534C08L2203/02C08L2205/02Y10T428/139Y10T428/1352
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,173,973
App. No.
13/370,394
Granted
Nov 3, 2015
Kind
B2
Abstract

A biodegradable and biocompatible nontoxic polymeric composition is provided which includes a base material such as a crystallizable polymer, copolymer, or terpolymer, and a copolymer or terpolymer additive. Medical devices manufactured from the composition are also provided.

Claims (7)

1. A method for making a bioabsorbable stent comprising the steps of:

(a) blending a polymer composition comprising a crystallizable bioabsorbable polymer composition, wherein the crystallizable bioabsorbable polymer composition comprises a base polymer comprising a poly(L-lactide) moiety and/or poly(D-lactide) moiety, and/or poly L-lactide-co-PEG moiety, and/or poly D-lactide-co-PEG moiety, linked with a modifying copolymer thereof comprising poly(L-lactide-co-Tri-methylenecarbonate) and/or poly(D-lactide-co-Tri-methylene-carbonate) and/or poly(L-lactide-co-ε-caprolactone) and/or poly(D-lactide-co-ε-caprolactone) in the form of block copolymers or as blocky random copolymers; wherein the chirality of the polylactide segments of the modifying copolymer are opposite to the chirality of the polylactide segments of the base polymer; and

(b) molding or extruding said polymer composition to produce a tube, wherein the polymer composition forms a lactide racemate stereo complex crystal structure between the base polymer and the modifying polymer.

2. The method of claim 1 , further comprising the step of cutting the tube into a scaffold form using a laser after step (b), wherein the scaffold form comprises a cage-like mesh of meandering struts connected to hoop-like rings.

3. The method of claim 2 , wherein the hoop-like rings are positioned at at least one end of the tube.

4. The method of claim 2 , wherein the hoop-like rings are positioned at the middle portion of the tube.

5. The method of claim 2 , wherein the meandering struts comprise a first and second set of meandering struts, wherein (i) the first and second sets of meandering struts alternate in a pattern of first and second meandering struts, (ii) the second meandering struts form a hoop shape after expansion, and (iii) the crystallinity of the second meandering struts after expansion is greater than the crystallinity of the first meandering struts after expansion.

Assignments (3)
CHANGE OF ADDRESS Recorded Jun 15, 2022
From: ORBUSNEICH MEDICAL PTE. LTD.
To: ORBUSNEICH MEDICAL PTE. LTD.
Reel/Frame 060386/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2019
From: ORBUSNEICH MEDICAL, INC.
To: ORBUSNEICH MEDICAL PTE. LTD.
Reel/Frame 048043/0879 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 6, 2016
From: THATCHER, G. LAWRENCE; COTTONE, ROBERT J.
To: ORBUSNEICH MEDICAL, INC.
Reel/Frame 039641/0697 →
Continuity (5)
Continuation 12508442 · Jul 23, 2009
Division 11781230 · Jul 20, 2007
Provisional Application 60862433 · Oct 20, 2006
Provisional Application 60807932 · Jul 20, 2006
Related Publication 20120142869A1 · Jun 7, 2012